Evidence map›Paper›PMID 35142345›Full record

ArticleDisease models & mechanisms2022

A genetic screen in Drosophila reveals the role of fucosylation in host susceptibility to Candida infection.

Marcus T Glittenberg, Ilias Kounatidis, Magda Atilano, Petros Ligoxygakis

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. The utility ofFrontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marcus T GlittenbergDepartment of Biochemistry, University of Oxford, South Parks Rd, Oxford OX1 3QU, UK.
Ilias KounatidisDepartment of Biochemistry, University of Oxford, South Parks Rd, Oxford OX1 3QU, UK.ORCID 0000-0001-9877-0457
Magda AtilanoDepartment of Biochemistry, University of Oxford, South Parks Rd, Oxford OX1 3QU, UK.ORCID 0000-0002-3819-2023
Petros LigoxygakisDepartment of Biochemistry, University of Oxford, South Parks Rd, Oxford OX1 3QU, UK.ORCID 0000-0002-9498-9993
University of Oxford · GB

Funding

Medical Research Council G0300170National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K500392/1Wellcome TrustWellcome Trust WT087680MA
6 · The paper itself

Abstract

Candida infections constitute a blind spot in global public health as very few new anti-fungal drugs are being developed. Genetic surveys of host susceptibilities to such infections using mammalian models have certain disadvantages in that obtaining results is time-consuming, owing to relatively long lifespans, and these results have low statistical resolution because sample sizes are usually small. Here, we report a targeted genetic screening of 5698 RNAi lines encompassing 4135 Drosophila genes with human homologues, several of which we identify as important for host survival after Candida albicans infection. These include genes in a variety of functional classes encompassing gene expression, intracellular signalling, metabolism and enzymatic regulation. Analysis of one of the screen hits, the infection-induced α-(1,3)-fucosylase FucTA, showed that N-glycan fucosylation has several targets among proteins involved in host defence, which provides multiple avenues of investigation for the mechanistic analysis of host survival to systemic C. albicans infection.

Indexed as

CandidiasisDrosophilaAnimalsCandida albicansGenetic TestingMammalsRNA InterferenceCandida albicansDrosophilaFucosylationGenetic screenHost-pathogen interaction

Identifiers

PMID35142345
PMCPMC9118035
OpenAlexW4211092905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.